Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Ahsan Khan as a ...

Fintel reports that on February 20, 2025, Piper Sandler upgraded their outlook for Clearwater Analytics Holdings (NYSE:CWAN) ...

Piper Sandler analyst John Barnidge maintained a Buy rating on Trupanion (TRUP – Research Report) today and set a price target of $52.00. The ...

In a report released today, Jason Bednar from Piper Sandler maintained a Buy rating on Pulmonx (LUNG – Research Report), with a price target of ...

Allspring Global Investments Holdings LLC lessened its holdings in Piper Sandler Companies (NYSE:PIPR – Free Report) by 36.4% ...

Van ECK Associates Corp acquired a new position in shares of Piper Sandler Companies (NYSE:PIPR – Free Report) during the ...

Olin ( NYSE: OLN) on Thursday was downgraded to Neutral from a previous investment rating of Overweight by analysts at ...

Fintel reports that on February 19, 2025, Piper Sandler initiated coverage of Compass Therapeutics (NasdaqCM:CMPX) with a Overweight recommendation. Analyst Price Forecast Suggests 232.44% Upside As ...

Piper Sandler adjusted its model to reflect fourth-quarter and full-year 2024 earnings, 2025 guidance, and industry checks on raw material costs, construction activity, and export markets. It ...

Piper Sandler Companies reported robust fourth-quarter 2024 earnings, with earnings per share (EPS) of $4.8, surpassing the forecast of $3.93. The company's revenue reached $499 million ...

Piper Sandler reported Q4 2024 adjusted net revenues of $499 million, exceeding analysts' revenue estimates of $454.36 million. Adjusted EPS of $4.80 also surpassed the analysts' EPS estimate of ...

Piper Sandler said it sees little data supporting a volume or price recovery through most of 2025, with potential spillover into 2026, prompting the revised outlook. Related Articles Piper Sandler ...